Platform
Features
0 followers
Design Therapeutics is pioneering novel small-molecule therapeutic candidates, called gene targeted chimeras (GeneTACs™), designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
Industries
Headquarters
Stage
Employees
Links
20 members
8 members
7 members
5 members
2 members
3 members
IES Abroad
1 follower
Catalent
13 followers
Lexicon Pharmaceuticals
Center for Management Studies
6 followers
Clario
4 followers
Great Minds
AbbVie
149 followers
Coursera
142 followers
Incyte
14 followers
Exo
3 followers
PowerSchool
12 followers
Discover companies